| 摘要 |
FIELD: pharmaceuticals.SUBSTANCE: invention relates to pharmaceutical industry and is a composition comprising at least one N-acetyllactosamine selected from a group consisting of lacto-N-tetraose and lacto-N-neotetraose of at least one sialylated oligosaccharide and at least one fucosylated oligosaccharide and a hydrolysate comprising partially and/or highly hydrolysed proteins, which is preferably from 10 % to 100 %, preferably from 15 % to 95 % of population of proteins/peptides having a molecular weight less than 1,000 Da, for use in prevention and/or treatment of atopic dermatitis and eczema.EFFECT: invention provides wider range of agents used in preventing and/or treating atopic dermatitis and eczema.17 cl, 1 ex, 4 dwg, 1 tbl |
